Company Filing History:
Years Active: 2023-2025
Title: Juliane Nguyen: Innovator in Cellular Modulation
Introduction
Juliane Nguyen is a prominent inventor based in Buffalo, NY (US). She has made significant contributions to the field of cellular modulation through her innovative research and patented technologies. With a total of 3 patents, her work focuses on developing methods to influence cellular functions, particularly in the context of cancer treatment.
Latest Patents
Nguyen's latest patents include groundbreaking compositions and methods aimed at blocking and binding CXCR4 to modulate cellular function. This patent provides compositions comprising antibodies directed to the N-terminal domain of CXCR4. The antibody may be a single-chain variable fragment (scFv) and can be fused to an RNA binding peptide. The fusion protein can be complexed to RNA interference (RNAi) molecules, such as micro RNA, allowing for targeted delivery to CXCR4-expressing cancer cells while inhibiting the binding of CXCR4 to CXCL12.
Another notable patent focuses on compositions and methods to block and bind CCR2 to modulate cellular function. This invention provides single-chain variable fragment antibodies directed against the N-terminal or extracellular loop regions of CCR2. These scFvs can be utilized alone or in combination to modify macrophage number and migration, ultimately reducing tumor growth.
Career Highlights
Juliane Nguyen is affiliated with the State University of New York, where she conducts her research and develops her innovative technologies. Her work has garnered attention in the scientific community, contributing to advancements in cancer treatment and cellular biology.
Collaborations
Nguyen collaborates with esteemed colleagues, including Scott Ferguson and Michael Deci, to further her research and enhance the impact of her inventions.
Conclusion
Juliane Nguyen is a trailblazer in the field of cellular modulation, with her innovative patents paving the way for new cancer therapies. Her dedication to research and collaboration continues to drive advancements in medical science.